Filtros de búsqueda

Lista de obras de Andrew Kuykendall

AML-488 Impact of Somatic Mutations on Treatment Response and Outcomes in Patients With Core Binding Factor Acute Myeloid Leukemia

artículo científico publicado en 2022

Between a rux and a hard place: evaluating salvage treatment and outcomes in myelofibrosis after ruxolitinib discontinuation

artículo científico publicado en 2017

Driver mutation-specific clinical and genomic correlates differ between primary and secondary myelofibrosis

artículo científico publicado en 2019

Finding a Jill for JAK: Assessing Past, Present, and Future JAK Inhibitor Combination Approaches in Myelofibrosis

artículo científico publicado en 2020

Fluorescence in Situ Hybridization (FISH) Utility for Risk Score Assessment in Patients With MDS With Normal Metaphase Karyotype

artículo científico publicado en 2020

Genetically inspired prognostic scoring system (GIPSS) outperforms dynamic international prognostic scoring system (DIPSS) in myelofibrosis patients

artículo científico publicado en 2018

Impact of High-Molecular-Risk Mutations on Transplantation Outcomes in Patients with Myelofibrosis

scientific article published on 06 January 2019

Molecular annotation of extramedullary acute myeloid leukemia identifies high prevalence of targetable mutations

artículo científico publicado en 2022

Monocyte subset analysis accurately distinguishes CMML from MDS and is associated with a favorable MDS prognosis

artículo científico publicado en 2017

Myeloid/Lymphoid Neoplasms with Eosinophilia and TK Fusion Genes, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology

artículo científico publicado en 2020

Persistent leukocytosis in polycythemia vera is associated with disease evolution but not thrombosis

scientific article published on 27 February 2020

Poster: AML-488 Impact of Somatic Mutations on Treatment Response and Outcomes in Patients With Core Binding Factor Acute Myeloid Leukemia

artículo científico publicado en 2022

Retrospective Analysis of the Clinical Use and Benefit of Lenalidomide and Thalidomide in Myelofibrosis

artículo científico publicado en 2020

Rusfertide, a Hepcidin Mimetic, for Control of Erythrocytosis in Polycythemia Vera

artículo científico publicado en 2024

Survival following allogeneic transplant in patients with myelofibrosis

artículo científico publicado en 2020

The Treatment Landscape of Myelofibrosis Before and After Ruxolitinib Approval.

artículo científico publicado en 2017

Treatment of MDS/MPN and the MDS/MPN IWG International Trial: ABNL MARRO

scientific article published on 01 December 2019

What's in a Number? Examining the Prognostic and Predictive Importance of Platelet Count in Patients With Essential Thrombocythemia

artículo científico publicado en 2020

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda